About Insulinoma-associated protein 1
Insulinoma-associated protein 1 (INSM1) is a protein
from Homo sapiens identified by UniProt accession
Q01101, 510 residues long.
MolForge cross-references it against 0 known binders and
273 disease associations.
Target properties
| Protein name | Insulinoma-associated protein 1 |
| UniProt accession | Q01101 |
| Gene | INSM1 |
| Organism | Homo sapiens |
| Length | 510 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (273)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.56
- age at menarche · score 0.31
- appendicular lean mass · score 0.28
- sitting height measurement · score 0.21
- insulin like growth factor measurement · score 0.21
- head and neck squamous cell carcinoma · score 0.18
- body height · score 0.12
- neoplasm · score 0.10
- small cell lung carcinoma · score 0.09
- lymphocyte count · score 0.09
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q01101-F1 | alphafold | PREDICTED | 58.38 | — |
Amino-acid sequence (510 residues)
MPRGFLVKRS KKSTPVSYRV RGGEDGDRAL LLSPSCGGAR AEPPAPSPVP GPLPPPPPAE RAHAALAAAL ACAPGPQPPP QGPRAAHFGN PEAAHPAPLY SPTRPVSREH EKHKYFERSF NLGSPVSAES FPTPAALLGG GGGGGASGAG GGGTCGGDPL LFAPAELKMG TAFSAGAEAA RGPGPGPPLP PAAALRPPGK RPPPPTAAEP PAKAVKAPGA KKPKAIRKLH FEDEVTTSPV LGLKIKEGPV EAPRGRAGGA ARPLGEFICQ LCKEEYADPF ALAQHKCSRI VRVEYRCPEC AKVFSCPANL ASHRRWHKPR PAPAAARAPE PEAAARAEAR EAPGGGSDRD TPSPGGVSES GSEDGLYECH HCAKKFRRQA YLRKHLLAHH QALQAKGAPL APPAEDLLAL YPGPDEKAPQ EAAGDGEGAG VLGLSASAEC HLCPVCGESF ASKGAQERHL RLLHAAQVFP CKYCPATFYS SPGLTRHINK CHPSENRQVI LLQVPVRPAC
Explore Insulinoma-associated protein 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets